Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

Upadacitinib improved multiple immune-related conditions in one patient.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

A patient with Birt-Hogg-Dubé Syndrome also had choroidal melanoma, suggesting the need for careful eyelid exams in such patients.

Finasteride and flutamide can effectively treat hirsutism, with abdominal hairs showing the most sensitivity to the treatment.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

Home IPL devices safely and effectively reduce hair and prevent pilonidal disease recurrence.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Baricitinib helps regrow hair in teens with severe alopecia areata.

A rare lupus case in Bangladesh improved with specific treatment.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Baricitinib may effectively treat lichen planopilaris.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Narrowband UVB therapy significantly improved a child's rare skin condition.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

FMT for ulcerative colitis may also help with weight loss, hair loss, arthritis, and allergies.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.